Search results
Results from the WOW.Com Content Network
Brugada syndrome (BrS) is a genetic disorder in which the electrical activity of the heart is abnormal due to channelopathy. [2] It increases the risk of abnormal heart rhythms and sudden cardiac death. [2]
Sudden unexplained nocturnal death syndrome may refer to: Brugada syndrome , a genetic disorder in which the electrical activity within the heart is abnormal Sudden arrhythmic death syndrome (SADS), a sudden unexpected death of adolescents and adults, mainly during sleep
Long QT syndrome, the most common form of cardiac channelopathy, is characterized by prolonged ventricular repolarization, predisposing to a high risk of ventricular tachyarrhythmias (e.g., torsade de pointes), syncope, and sudden cardiac death.
Andersen–Tawil syndrome: This condition affects the QT interval (in blue) Antley–Bixler syndrome: Barth syndrome: Brugada syndrome: Cantú syndrome: genetic (Chromosome 12, autosomal dominant) Cardiac syndrome X: Cardiorenal syndrome: Kidney Cat eye syndrome: CHARGE syndrome: Coffin–Lowry syndrome: genetic (RPS6KA3 gene mutation ...
Long QT syndrome is estimated to affect 1 in 7,000 people. [6] Females are affected more often than males. [6] Most people with the condition develop symptoms before they are 40 years old. [6] It is a relatively common cause of sudden death along with Brugada syndrome and arrhythmogenic right ventricular dysplasia. [3]
Jay-Z's attorney claims the rape accusations against the rap mogul are "provably demonstrably false" and that multiple people are willing to come forward to debunk the allegations, according to ...
Symptoms of Peyronie’s Disease. The most apparent symptom of Peyronie’s disease is a deformity of the aroused privates, which can be a new curvature of the privates or a focal loss of aroused ...
Long QT syndrome, Brugada syndrome, Andersen-Tawil syndrome, Early repolarization syndrome: Treatment: Avoidance of strenuous exercise, medication, implantable cardioverter defibrillator [2] Medication: Beta-adrenoceptor blockers, Verapamil, Flecainide [2] Prognosis: 13–20% life threatening arrhythmias over 7–8 years [3] Frequency: 1:10,000 [4]